sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
2-Aug-2013 10:18
US Eastern Time

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Portal: Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 926-943 out of 943.

<< < 33 | 34 | 35 | 36 | 37 | 38

Public Release: 23-Aug-2011
British Journal of Dermatology
Prolonged breastfeeding does not protect against eczema, global study shows
The largest worldwide study on the association between breastfeeding, time of weaning and eczema in children has concluded that there is no clear evidence that exclusive breastfeeding for four months or longer protects against childhood eczema. The study, led by scientists at King's College London, and published online in the British Journal of Dermatology (BJD), concludes that children who were exclusively breastfed for four months or longer were as likely to develop eczema as children who were weaned earlier.

Contact: Katherine Barnes
katherine.barnes@kcl.ac.uk
44-020-784-83076
King's College London

Public Release: 19-Aug-2011
Proceedings of the National Academy of Sciences
Malaria parasites camouflage themselves from the immune defenses of expectant mothers
Collaborative research between LSTM and the University of Copenhagen, published last week in the Proceedings of the National Academy of Sciences, have answered a long standing mystery, why and how malaria parasites go unnoticed by the immune defenses of pregnant mothers. Maternal malaria kills 10,000 women and between 10,000 to 200,000 babies every year. Malaria is a preventable and treatable disease and every life lost is needless.

Contact: Richard Pleass
Richard.Pleass@liverpool.ac.uk
44-151-705-3315
Liverpool School of Tropical Medicine

Public Release: 18-Aug-2011
Nationwide trends for sepsis in the 21st century
Despite the increasing number of severe sepsis admissions and declining mortality rates, there are more patients being discharged to skilled nursing facilities and in-home care, which warrants increased attention.

Contact: Sue Roberts
sroberts@chestnet.org
847-498-8334
American College of Chest Physicians

Public Release: 16-Aug-2011
Largest global childhood pneumonia etiology study launched
This week, a groundbreaking new study called the Pneumonia Etiology Research for Child Health (PERCH) study gets off the ground. A collaboration between five African and two Asian research sites coordinated by the International Vaccine Access Center (IVAC) at Johns Hopkins Bloomberg School of Public Health, the study will systematically look at current and likely future causes of childhood pneumonia in some of the world's hardest hit populations.
Bill & Melinda Gates Foundation

Contact: Julie Younkin
jbuss@jhsph.edu
410-340-9784
International Vaccine Access Center

Public Release: 16-Aug-2011
UofL's Ruth Carrico selected for National Nurse Fellowship
Ruth Carrico, Ph.D., R.N., F.S.H.E.A., C.I.C., an associate professor at the School of Public Health and Information Sciences, University of Louisville, has been named one of just 21 Robert Wood Johnson Foundation Executive Nurse Fellows for 2011.
Robert Wood Johnson Foundation

Contact: Julie Heflin
julie.heflin@louisville.edu
502-852-7987
University of Louisville

Public Release: 16-Aug-2011
Journal of Applied Microbiology
A faster, cheaper way to diagnose TB
Researchers have discovered a faster, cheaper method for the diagnosis of tuberculosis (TB). A major barrier in TB prevention, especially in developing countries, is that diagnosis is slow and costly. Dr. Olivier Braissant and his colleagues have developed a method which could potentially decrease the time taken to make a diagnosis. Their method is also cheaper than the current fastest methods. This research has been published today in the Society for Applied Microbiology's Journal of Applied Microbiology.

Contact: Ben Norman
Lifesciencenews@wiley.com
44-012-437-70375
Wiley

Public Release: 14-Aug-2011
Nature Chemical Biology
Salmonella stays deadly with a 'beta' version of cell behavior
Salmonella cells have hijacked the protein-building process to maintain their ability to cause illness, new research suggests. Scientists say that these bacteria have modified what has long been considered typical cell behavior by using a beta form of an amino acid -- as opposed to an alpha form -- during the act of making proteins.
National Institutes of Health, Canadian Institutes of Health Research, Natural Sciences and Engineering Research Council of Canada

Contact: Michael Ibba
Ibba.1@osu.edu
614-292-2120
Ohio State University

Public Release: 12-Aug-2011
Clinical Journal of the American Society of Nephrology
Poor growth, delayed puberty and heart problems plague kids with mild kidney disease
Heart disease causes 35 percent of deaths in young adults with chronic kidney disease. Children with only mildly impaired kidney function experience poor growth, delayed puberty, metabolic problems, and high blood pressure. Treating these conditions during childhood might slow kidney disease and prevent heart-related deaths in young adults.

Contact: Adrienne Lea
alea@asn-online.org
American Society of Nephrology

Public Release: 11-Aug-2011
Science
Researchers decode workings of mysterious, but critical TB drug
A new study, led by researchers at the Johns Hopkins Bloomberg School of Public Health, suggests that PZA binds to a specific protein named RpsA and inhibits trans-translation, a process that enables the TB bacteria to survive under stressful conditions.
NIH/National Institute of Allergy and Infectious Diseases, National Key Technologies Research and Development Program of China

Contact: Natalie Wood-Wright
nwoodwri@jhsph.edu
410-614-6029
Johns Hopkins University Bloomberg School of Public Health

Public Release: 11-Aug-2011
New TB vaccine enters proof-of-concept trial in people living with HIV
Aeras and the Oxford-Emergent Tuberculosis Consortium (OETC) announce today the start of a Phase IIb proof-of-concept efficacy trial of a new investigational tuberculosis (TB) vaccine that involves people living with the human immunodeficiency virus (HIV). The trial will be conducted at research sites in Senegal and South Africa with primary funding support from the European and Developing Countries Clinical Trials Partnership (EDCTP).

Contact: Annmarie Leadman
aleadman@aeras.org
240-599-3018
Aeras

Public Release: 10-Aug-2011
PLOS Medicine
Blood tests for active TB not accurate or cost-effective
Commercial blood serum antibody tests are not accurate or cost-effective, according to an analysis by researchers at the Johns Hopkins Bloomberg School of Public Health, the University of Washington School of Public Health and McGill University.
Stop TB Partnership's New Diagnostics Working Group, Canadian Institutes of Health Research

Contact: Tim Parsons
tmparson@jhsph.edu
410-955-6878
Johns Hopkins University Bloomberg School of Public Health

Public Release: 10-Aug-2011
Journal of Experimental Medicine
Trudeau Institute announces new discovery in battle against infections
Researchers from Dr. Woodland's lab at the Trudeau Institute have now identified a previously unknown link between the migration of white blood cells to infected tissues and the ability of these cells to survive and become long-lived memory cells after the infection has been cleared. The new data is featured on the cover of this month's the Journal of Experimental Medicine.
National Institutes of Health

Contact: Karen Sharma
518-891-3080
Trudeau Institute

Public Release: 10-Aug-2011
American Journal of Clinical Nutrition
Red meat linked to increased risk of type 2 diabetes
A new study by Harvard School of Public Health researchers finds a strong association between the consumption of red meat -- particularly when the meat is processed -- and an increased risk of type 2 diabetes. The study also shows that replacing red meat with healthier proteins, such as low-fat dairy, nuts, or whole grains, can significantly lower the risk.
NIH/National Institute of Diabetes and Digestive and Kidney Diseases, NIH/National Heart, Lung and Blood Institute

Contact: Marge Dwyer
mhdwyer@hsph.harvard.edu
617-432-8416
Harvard School of Public Health

Public Release: 8-Aug-2011
Jefferson receives $4.8 million NIH grant to study new rabies vaccine that clears virus from brain
Thomas Jefferson University received a National Institutes of Health $4.8 million grant to test a new rabies vaccine with the potential to cure the virus infection, even after it has made its way into a person's central nervous system. Today, if an unvaccinated person is infected with rabies and it spreads to the brain, there is little chance for survival.

Contact: Steve Graff
stephen.graff@jefferson.edu
215-955-5291
Thomas Jefferson University

Public Release: 4-Aug-2011
First scorpion antivenom approved by FDA
The highest concentration of dangerous bark scorpions in the United States is in Arizona, where about 8,000 scorpion stings occur each year. Several hundred of these result in serious nerve poisoning and require medical treatment. Nearly all of these patients are young children, whose breathing may be severely affected by the effects of the venom, necessitating heavy sedation, intensive supportive care and, often, ventilation. A newly approved antivenom, Anascorp, relieves symptoms quickly.
FDA Office of Orphan Products Development, Arizona Department of Health Services, Arizona Biomedical Research Commission, Instituto Bioclon, Rare Disease Therapeutics Inc.

Contact: Ann Cisneros
ann@email.arizona.edu
520-626-7237
University of Arizona Health Sciences Center

Public Release: 4-Aug-2011
Immunity
Targeting innate immunity in malaria
Scientists at the University of Massachusetts Medical School have uncovered a novel DNA-sensing pathway important to the triggering of an innate immune response for malaria. Activation of this pathway appears to stimulate production of an overabundance of type-1 interferon by the immune system that may contribute to inflammation and fever in malaria patients and could play a part in susceptibility for the most common and lethal form of malaria known as plasmodium falciparum.

Contact: Jim Fessenden
james.fessenden@umassmed.edu
508-856-2000
University of Massachusetts Medical School

Public Release: 3-Aug-2011
Lancet
Text message reminders improve healthcare practice in rural Africa, study finds
New research funded by the Wellcome Trust has shown that sending text message reminders to health-care workers in rural Africa can improve the implementation of national guidelines for treating malaria. The intervention led to more patients receiving accurate antimalarial treatment.
Wellcome Trust

Contact: Craig Brierley
c.brierley@wellcome.ac.uk
44-207-611-7329
Wellcome Trust

Public Release: 3-Aug-2011
American Journal of Tropical Medicine and Hygiene
Scientists pinpoint river flow associated with cholera outbreaks, not just global warming
An examination of the world's largest river basins found nutrient-rich and powerful river discharges led to spikes in the blooms of plankton associated with cholera outbreaks. These increased discharges often occur at times of increased temperature in coastal water, suggesting that predicting global warming's potential temperature effect on cholera will be more complicated than first thought, according to a new study published today in the American Journal of Tropical Medicine and Hygiene.
National Institutes of Health

Contact: Bridget DeSimone
bdesimone@burnesscommunications.com
301-280-5735
American Society of Tropical Medicine and Hygiene

Showing releases 926-943 out of 943.

<< < 33 | 34 | 35 | 36 | 37 | 38